Bevacizumab-induced tumor calcifications as a surrogate marker of outcome in patients with glioblastoma

Por Bähr, Oliver, Hattingen, Elke, Rieger, Johannes, Steinbach, Joachim P.
Publicado em 2011

Current standards and new concepts in MRI and PET response assessment of antiangiogenic therapies in high-grade glioma patients

Por Hutterer, Markus, Hattingen, Elke, Palm, Christoph, Proescholdt, Martin Andreas, Hau, Peter
Publicado no Neuro Oncol (2015)

Diffusion tensor tracking of fornix infarction

Por Hattingen, Elke, Rathert, Julian, Raabe, Andreas, Anjorin, Angela, Lanfermann, Heinrich, Weidauer, Stefan
Publicado em 2007

Phospholipid Metabolites in Recurrent Glioblastoma: In Vivo Markers Detect Different Tumor Phenotypes before and under Antiangiogenic Therapy

Por Hattingen, Elke, Bähr, Oliver, Rieger, Johannes, Blasel, Stella, Steinbach, Joachim, Pilatus, Ulrich
Publicado em 2013

Central nervous system imaging in childhood Langerhans cell histiocytosis – a reference center analysis

Por Porto, Luciana, Schöning, Stefan, Hattingen, Elke, Sörensen, Jan, Jurcoane, Alina, Lehrnbecher, Thomas
Publicado no Radiol Oncol (2015)

T2’-Imaging to Assess Cerebral Oxygen Extraction Fraction in Carotid Occlusive Disease: Influence of Cerebral Autoregulation and Cerebral Blood Volume

Por Seiler, Alexander, Deichmann, Ralf, Pfeilschifter, Waltraud, Hattingen, Elke, Singer, Oliver C., Wagner, Marlies
Publicado no PLoS One (2016)

Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival

Por Hattingen, Elke, Jurcoane, Alina, Daneshvar, Keivan, Pilatus, Ulrich, Mittelbronn, Michel, Steinbach, Joachim P., Bähr, Oliver
Publicado em 2013

Reduction of microbleeds by immunosuppression in a patient with Aβ-related vascular inflammation

Por Traschütz, Andreas, Tzaridis, Theophilos, Penner, Arndt-Hendrik, Kuchelmeister, Klaus, Urbach, Horst, Hattingen, Elke, Heneka, Michael T.
Publicado no Neurol Neuroimmunol Neuroinflamm (2015)

Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A (1)H-Magnetic Resonance Spectroscopy Study

Por Steidl, Eike, Pilatus, Ulrich, Hattingen, Elke, Steinbach, Joachim P., Zanella, Friedhelm, Ronellenfitsch, Michael W., Bähr, Oliver
Publicado no PLoS One (2016)

Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a (31)P/(1)H MRSI and quantitative magnetic resonance imaging study

Por Hattingen, Elke, Jurcoane, Alina, Bähr, Oliver, Rieger, Johannes, Magerkurth, Jörg, Anti, Sandra, Steinbach, Joachim P., Pilatus, Ulrich
Publicado em 2011

Value of quantitative magnetic resonance imaging T1-relaxometry in predicting contrast-enhancement in glioblastoma patients

Por Hattingen, Elke, Müller, Andreas, Jurcoane, Alina, Mädler, Burkhard, Ditter, Philip, Schild, Hans, Herrlinger, Ulrich, Glas, Martin, Kebir, Sied
Publicado no Oncotarget (2017)

Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance?

Por Niyazi, Maximilian, Harter, Patrick N., Hattingen, Elke, Rottler, Maya, von Baumgarten, Louisa, Proescholdt, Martin, Belka, Claus, Lauber, Kirsten, Mittelbronn, Michel
Publicado no Oncotarget (2015)

Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-gra...

Por Kebir, Sied, Khurshid, Zain, Gaertner, Florian C., Essler, Markus, Hattingen, Elke, Fimmers, Rolf, Scheffler, Björn, Herrlinger, Ulrich, Bundschuh, Ralph A., Glas, Martin
Publicado no Oncotarget (2016)

Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy

Por Maurer, Gabriele D, Brucker, Daniel P, Bähr, Oliver, Harter, Patrick N, Hattingen, Elke, Walenta, Stefan, Mueller-Klieser, Wolfgang, Steinbach, Joachim P, Rieger, Johannes
Publicado em 2011

Proton 1H- and Phosphorus 31P-MR spectroscopy (MRS) in asymptomatic HIV-positive patients

Por Schuettfort, Gundolf, Hattingen, Elke, Pilatus, Ulrich, Stephan, Christoph, Wolf, Timo, Goepel, Siri, Haberl, Annette, Blasel, Stella, Zanella, Freidhelm, Brodt, Hans-Reinhard, Bickel, Markus
Publicado no J Int AIDS Soc (2014)

SMART: physical activity and cerebral metabolism in older people: study protocol for a randomised controlled trial

Por Fleckenstein, Johannes, Matura, Silke, Engeroff, Tobias, Füzéki, Eszter, Tesky, Valentina A, Pilatus, Ulrich, Hattingen, Elke, Deichmann, Ralf, Vogt, Lutz, Banzer, Winfried, Pantel, Johannes
Publicado no Trials (2015)

Quantitative T1‐mapping detects cloudy‐enhancing tumor compartments predicting outcome of patients with glioblastoma

Por Müller, Andreas, Jurcoane, Alina, Kebir, Sied, Ditter, Philip, Schrader, Felix, Herrlinger, Ulrich, Tzaridis, Theophilos, Mädler, Burkhard, Schild, Hans H., Glas, Martin, Hattingen, Elke
Publicado no Cancer Med (2016)

Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastases

Por Kebir, Sied, Rauschenbach, Laurèl, Galldiks, Norbert, Schlaak, Max, Hattingen, Elke, Landsberg, Jennifer, Bundschuh, Ralph A., Langen, Karl-Josef, Scheffler, Björn, Herrlinger, Ulrich, Glas, Martin
Publicado no Neuro Oncol (2016)

O-(2-(18)F-fluoroethyl)-L-tyrosine PET for evaluation of brain metastasis recurrence after radiotherapy: an effectiveness and cost-effectiveness analysis

Por Heinzel, Alexander, Müller, Dirk, Yekta-Michael, Sareh Said, Ceccon, Garry, Langen, Karl-Josef, Mottaghy, Felix M, Wiesmann, Martin, Kocher, Martin, Hattingen, Elke, Galldiks, Norbert
Publicado no Neuro Oncol (2017)

ERGO: A pilot study of ketogenic diet in recurrent glioblastoma

Por RIEGER, JOHANNES, BÄHR, OLIVER, MAURER, GABRIELE D., HATTINGEN, ELKE, FRANZ, KEA, BRUCKER, DANIEL, WALENTA, STEFAN, KÄMMERER, ULRIKE, COY, JOHANNES F., WELLER, MICHAEL, STEINBACH, JOACHIM P.
Publicado em 2014